This text will be used as a preview snippet in most modern email clients.
Email not displaying correctly? View it in your browser.
eMediNews
(Incorporating IMA News)
30th January 2016
Editorial
World Cancer Day - IMA joins global efforts to reduce cancer burden

Dear Colleagues
This year, World Cancer Day is being observed on February 4. The theme is ‘We can. I can’.
 
The three year campaign, 2016-2018 will explore how everyone – together or individually – can do their part to reduce the global burden of cancer and bring about a change. All people have the power to take various actions to reduce the impact that cancer has on individuals, families and communities
 
The Union for International Cancer Control (UICC) began the World Cancer Day to help save millions of preventable deaths each year by raising awareness and education about cancer, and pressing governments and individuals across the world to take action against the disease. It is observed in almost the whole world as an annual event.

Dr SS Agarwal                  Dr KK Aggarwal               Dr Dilip K Acharya
National President, IMA             Hony Secy Gen IMA       Chairman IMA National Cancer & Tobacco Control Committee 
To Read More or Comment, Click Here
WHO is not recommending any travel/trade restrictions related to Zika virus disease
 
Dear Dr KK Aggarwal
 
As discussed over the phone today, for Zika virus related information kindly refer to the WHO FAQs and travel advisories http://www.who.int/features/qa/zika/en/ One of the questions articulates the WHO travel advisory quite well; Based on available evidence, WHO is not recommending any travel or trade restrictions related to Zika virus disease. As a precautionary measure, some national governments have made public health and travel recommendations to their own populations, based on their assessments of the available evidence and local risk factors.
 
Meanwhile WHO is convening the Emergency Committee on 1st Feb to look into temporary recommendations and further analyze evidence. As new evidence becomes available, WHO may revise its recommendations which will be available on WHO website. MoHFW is also likely to come out with guidelines soon. This is for your information, reference and necessary action please
 
Dr Rajesh Narwal, MD, MPH
Technical Officer- Health Systems Stewardship and Regulations
Breaking News
Zika Virus Update

WHO will convene an emergency meeting Monday to determine if the Zika virus outbreak should be declared a public health emergency?

Specialty Updates
Video of the Day
   Dr Good Dr Bad                                                          Make Sure
eIMA News Update
IMA Updates
 IMA Polio Dates
  • April 1st: tOPV would not be available after this date.
  • April 11th: bOPV would be available in private market but it is not to be opened or used before 25th April.
  • April 25: IMA Polio Switch Day, when tOPV would be completely withdrawn and replaced by bOPV in both routine immunization and polio campaigns.
  • 9th May: IMA National Validation Day when India would be declared free of tOPV. 

IMA Satyagraha - https://www.youtube.com/watch?v=UV1zCH33BlU

What's Your Take?
To Read More or Comment, Click Here
Lifestyle Updates

eWellness - Shoe Hygiene

eSpiritual -  How to remove negative thoughts

Inspirational Story - The stone soup story

Lighter Reading
Medicolegal Corner

Legal Question - Can an allopathic doctor employ a Unani or Ayurveda doctor?

Bioethical issues in medical practice - Blood transfusion to a Jehovah's Witness follower

eMedi Quiz
Photo Quiz
You notice bowel sounds are audible in the chest of this 13-yr-old boy. After examining this X-ray what would you conclude?
Press Release
Kesari dal being reintroduced: Too early for IMA to call it 100% safe
 
New Delhi:Three new varieties of kesari dal, Ratan, Prateek and Mahateora, which have low p-N oxalyl- L-p-diaminopropionic acid (P-ODAP) content, have been released for general cultivation. Kesari dal or lathyrus sativus is commonly known as grass pea. The Indian Council of Agricultural Research (ICAR) has developed these three new strains in collaboration with State agriculture universities. Kesari dal, a key Rabi pulse crop, is mainly cultivated in the states of Madhya Pradesh, Chhattisgarh, Maharashtra, Bihar and West Bengal. Arhar dal is expensive and often retailers mix the cheap khesari dal because of similarity in appearance
 

ODAP is found in the seeds of Kesari Dal at a constant concentration of 0.5%. While, the ODAP content in these varieties is in the range of 0.07-0.10%, which is safe for human consumption, it has been shown that the concentration of ODAP increases in plants grown under stressful conditions. It is learnt that the ICAR admitted that a research panel headed by India Council of Medical Research has proposed lifting the earlier ban on Kesari dal. According to them, in the new varieties of the dal, the toxicity is "negligible." The Food Safety and Standards Authority of India (FSSAI) is now considering the proposal.

 

Sharing IMA’s viewpoint, Dr S S Agarwal, National President, IMA and Padma Shri Awardee, Dr K K Aggarwal, Hony. Secretary General, IMA in a joint statement said, “IMA would like to know more about the studies, animal studies and long term follow ups before our members can call it 100% safe for human consumption. The word negligible also needs clarification”.


Lathyrism, a disorder of spastic paraparesis occurs in association with increased dietary intake of food plants with neurotoxic potential. Neurolathyrism is associated with prolonged consumption of the grass pea. Exposed persons suffer a slowly developing spastic paraparesis with cramps, paresthesias and numbness, accompanied by bladder symptoms and impotence. Some patients have tremors and other involuntary movements in their arms. Pathologic studies have demonstrated a loss of myelinated fibers in the corticospinal and spinocerebellar tracts. The toxin appears to be the neuroexcitatory amino acid, beta-N-oxalylaminoalanine. There is no treatment.

Digital IMA
The Indian Medical Association (IMA) presents a series of weekly webcasts for the benefit of the Indian medical profession, engaging you with the latest in advocacy efforts for doctors, through an interactive exclusive digital webcast partnership with eMediNexus.

Next Webcast: 4th February 2016
Topic- Cancer Prevention